Ocean Bio-Chem Stock Is Believed To Be Significantly Overvalued

Author's Avatar
GF Value
Jul 14, 2021
Article's Main Image

The stock of Ocean Bio-Chem (NAS:OBCI, 30-year Financials) shows every sign of being significantly overvalued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. If the price of a stock is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher. At its current price of $12.0579 per share and the market cap of $114.3 million, Ocean Bio-Chem stock shows every sign of being significantly overvalued. GF Value for Ocean Bio-Chem is shown in the chart below.

1415174372976582656.png?1626238820

Because Ocean Bio-Chem is significantly overvalued, the long-term return of its stock is likely to be much lower than its future business growth, which averaged 12.7% over the past five years.

Link: These companies may deliever higher future returns at reduced risk.

It is always important to check the financial strength of a company before buying its stock. Investing in companies with poor financial strength have a higher risk of permanent loss. Looking at the cash-to-debt ratio and interest coverage is a great way to understand the financial strength of a company. Ocean Bio-Chem has a cash-to-debt ratio of 2.56, which is better than 75% of the companies in Conglomerates industry. The overall financial strength of Ocean Bio-Chem is 8 out of 10, which indicates that the financial strength of Ocean Bio-Chem is strong. This is the debt and cash of Ocean Bio-Chem over the past years:

1415174378190102528.png

Companies that have been consistently profitable over the long term offer less risk for investors who may want to purchase shares. Higher profit margins usually dictate a better investment compared to a company with lower profit margins. Ocean Bio-Chem has been profitable 10 over the past 10 years. Over the past twelve months, the company had a revenue of $60.9 million and earnings of $1.15 a share. Its operating margin is 22.90%, which ranks better than 91% of the companies in Conglomerates industry. Overall, the profitability of Ocean Bio-Chem is ranked 8 out of 10, which indicates strong profitability. This is the revenue and net income of Ocean Bio-Chem over the past years:

1415174381990141952.png

Growth is probably one of the most important factors in the valuation of a company. GuruFocus’ research has found that growth is closely correlated with the long-term performance of a company’s stock. If a company’s business is growing, the company usually creates value for its shareholders, especially if the growth is profitable. Likewise, if a company's revenue and earnings are declining, the value of the company will decrease. Ocean Bio-Chem’s 3-year average revenue growth rate is better than 81% of the companies in Conglomerates industry. Ocean Bio-Chem’s 3-year average EBITDA growth rate is 42.7%, which ranks better than 92% of the companies in Conglomerates industry.

Another way to evaluate a company’s profitability is to compare its return on invested capital (ROIC) to its weighted cost of capital (WACC). Return on invested capital (ROIC) measures how well a company generates cash flow relative to the capital it has invested in its business. The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. If the ROIC is higher than the WACC, it indicates that the company is creating value for shareholders. Over the past 12 months, Ocean Bio-Chem’s ROIC was 31.96, while its WACC came in at 3.54. The historical ROIC vs WACC comparison of Ocean Bio-Chem is shown below:

1415174385379139584.png

In closing, The stock of Ocean Bio-Chem (NAS:OBCI, 30-year Financials) is estimated to be significantly overvalued. The company's financial condition is strong and its profitability is strong. Its growth ranks better than 92% of the companies in Conglomerates industry. To learn more about Ocean Bio-Chem stock, you can check out its 30-year Financials here.

To find out the high quality companies that may deliever above average returns, please check out GuruFocus High Quality Low Capex Screener.

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
Rating:
0 / 5 (0 votes)

Please Login to leave a comment

Author's Avatar